The Rest Of Europe Gummy Supplements Market was valued at $611.5 Million in 2025 and projected to reach to $1111.7 Million by 2030, representing a compound annual growth rate of 12.7%. Rest Of Europe's gummy supplements market is positioned for sustained expansion through 2030, driven by evolving consumer preferences toward convenient, taste-friendly supplement delivery systems.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Europe's gummy supplements market is valued at USD 611.5 million in 2025, with projections to reach USD 1,111.7 million by 2030, representing significant investment opportunities across the region.
The region demonstrates a robust 12.7% compound annual growth rate, slightly outpacing broader European trends and indicating sustained consumer demand for convenient supplement formats in Rest Of Europe markets.
Rest Of Europe consumers increasingly favor gummy supplements over traditional tablets and capsules, driven by improved palatability, ease of consumption, and perceived better bioavailability in the regional market.
Rising health awareness across Rest Of Europe is propelling market growth, with consumers actively seeking preventive wellness solutions and nutritional supplementation as part of their daily health routines.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | CBD GUMMIES (Product Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 14.4% from 2025 to 2030 |
| Largest Segment | ADULTS (Demographics) |
| Market Size Base Year (Billions) | ~USD 24.39 (2025) |
| Revenue Forecast (Billions) | ~USD 47.79 (2030) |
| Segments Covered | Product Type, Demographics, Distribution Channel, Ingredient Source |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AZELIS HOLDINGS SA | Belgium | Private Company | Life sciences (food, nutrition, pharma, personal and home care),Industrial specialties (coatings, plastics, lubricants, advanced materials),Other and cross-segment services, |
| CHURCH & DWIGHT CO., INC. | United States | Public Company | Household care (ARM & HAMMER, OXICLEAN, XTRA, cat litter, deodorizers),Personal care and wellness (TROJAN, FIRST RESPONSE, NAIR, ORAJEL, ZICAM, TOUCHLAND),Premium beauty and skincare (BATISTE, HERO), |
| H&H GROUP | Hong Kong | Public Company | Pediatric nutrition & baby care,Adult nutrition, vitamins & supplements,Pet nutrition & supplements, |
| AMWAY | United States | Public Company | Health and wellness (NUTRILITE, bodykey, XS),Beauty and personal care (ARTISTRY, G&H, GLISTER, SATINIQUE),Home and living systems (eSpring, ATMOSPHERE, Amway Home), |
| BAYER AG | Germany | Public Company | Pharmaceuticals (cardiology, women’s health, specialty therapeutics, imaging, cell and gene therapy),Crop Science (crop protection, traits, seeds, digital ag, pest and weed management),Consumer Health (OTC, self-care, supplements, allergy, cough/cold, dermatology, pain, digestive), |
| NESTLE | Switzerland | Public Company | Coffee (Nescafé, Nespresso, Starbucks At Home, Blue Bottle, Roastelier),Petcare (Purina, Dog Chow, Cat Chow, Pro Plan, Felix, Friskies),Confectionery and Ice Cream (KitKat, Smarties, Häagen-Dazs, Mövenpick, Drumstick), |
| UNILEVER | United Kingdom | Public Company | Beauty & Wellbeing,Personal Care,Home Care, |
| OTSUKA HOLDINGS CO., LTD. | Japan | Public Company | Specialty Pharmaceuticals (psychiatry, neurology, oncology, cardiovascular/renal, autoimmune, digestive, ophthalmology),IV Solutions, Infusion and Clinical Nutrition, Medical Devices, Diagnostics,Nutraceuticals, Functional Foods, Soft Drinks, Beverages, Nutritional Products, Dietetic Foods, |
| PHARMACARE LABORATORIES AUSTRALIA | Australia | Private Company | Vitamins and Dietary Supplements,Personal Care and Beauty,Other Healthcare and OTC Products, |
Azelis Holdings SA is a Belgian private company founded in 2001 with 1,325 employees.
Church & Dwight Co., Inc. is a publicly traded American company established in 1846, operating with 5,550 employees.
H&H Group is a Hong Kong-based public company founded in 1999 with 2,758 employees.
Amway is a publicly traded American company founded in 1976 with 308 employees.
Bayer AG is a German multinational public company established in 1863, employing 87,757 people.
Nestlé is a Swiss multinational public company founded in 1866 with 271,000 employees.
Unilever is a United Kingdom-based public company established in 1860 with 93,732 employees.
Otsuka Holdings Co., Ltd. is a Japanese public company founded in 1921 with 37,758 employees.
Pharmacare Laboratories Australia is an Australian private company established in 1985 with 685 employees.
Rest Of Europe's gummy supplements market is valued at USD 611.5 million in 2025.
Rest Of Europe's gummy supplements market is forecast to reach USD 1,111.7 million by 2030.
Rest Of Europe's gummy supplements market is growing at a compound annual growth rate of 12.7% from 2025 to 2030.
Rest Of Europe's market growth is driven by increasing health consciousness, demand for convenient supplement formats, innovation in functional ingredients, and expanding e-commerce distribution channels.
Rest Of Europe's 12.7% CAGR demonstrates strong regional momentum, reflecting robust consumer adoption and market maturation compared to the global average of 14.4%.
The study employed two primary approaches to estimate the current size of the gummy supplements market. Exhaustive secondary research was conducted to gather information on the market, peer markets, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. The top-down and bottom-up approaches were used to estimate the complete market size. Thereafter, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
This research study extensively utilized secondary sources, including directories and databases such as Bloomberg Businessweek and Factiva, to identify and collect information relevant to a technical, market-oriented, and commercial study of the market. In the secondary research process, various sources, including company annual reports, press releases, investor presentations, white papers, food journals, certified publications, articles by recognized authors, directories, and databases, were utilized to identify and collect information.
Secondary research was primarily used to gather key information about the industry’s supply chain, the total pool of key players, and market classification and segmentation based on the industry trends to the most granular level, including regional markets and key developments from the market- and technology-oriented perspectives.
Extensive primary research was conducted after obtaining information regarding the gummy supplements market scenario through secondary research. Several primary interviews were conducted with market experts from the demand and supply sides across major countries of North America, Europe, Asia Pacific, South America, and the Rest of the World. Primary data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Experience Officers (CXOs), Vice Presidents (VPs), directors from business development, marketing, research, and development teams, and key opinion leaders.
Primary interviews were conducted to gather insights, including market statistics, revenue data from products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to gummy supplements segments based on type, end-use demographics, functionality, distribution channel, by starch ingredients, by ingredients source, and region. Stakeholders from the demand side, including research institutions, universities, and third-party vendors, were interviewed to gain insight into the buyer’s perspective on the service, their current use of gummy supplements and fungicides, and their business outlook, which will influence the overall market situation.
Note: The three tiers of the companies are defined based on their total revenues in 2023 or 2024, as per the
availability of financial data: Tier 1: Revenue > USD 1 billion; Tier 2: USD 100 million = Revenue = USD 1 billion; Tier 3:
Revenue < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
The top-down and bottom-up approaches were used to estimate and validate the total size of the gummy supplements market. These approaches were also used extensively to determine the size of various market segments. The research methodology used to estimate the market size includes the following details:

After determining the overall market size through the estimation process explained above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to estimate the overall gummy supplements market and determine the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. The market size was also validated using the top-down and bottom-up approaches.
According to the FDA, “Dietary supplements are intended to add to or supplement the diet and are different from conventional food. If a product is meant to treat, diagnose, cure, or prevent diseases, it is considered a drug, even if it is labeled as a dietary supplement. Supplements are ingested and come in various forms, including tablets, capsules, soft gels, gel caps, powders, bars, gummies, and liquids.”
The Dietary Supplement Health and Education Act (DSHEA) of 1994 defines a dietary supplement as “A dietary supplement is a product intended for ingestion that, among other requirements, contains a “dietary ingredient” intended to supplement the diet. The term “dietary ingredient” includes vitamins and minerals; herbs and other botanicals; amino acids; “dietary substances” that are part of the food supply, such as enzymes and live microbials (commonly referred to as “probiotics”); and concentrates, metabolites, constituents, extracts, or combinations of any dietary ingredient from the preceding categories.”
Gummy supplements are chewable dietary substances containing bioactive ingredients, such as vitamins, minerals, omega fatty acids, probiotics, prebiotics, and other substances having antioxidant properties that promote human health. Gummy supplements resemble the taste and texture of gummy candies. They are offered in various colors, flavors, and shapes, making them increasingly appealing, particularly to children. Gummy vitamins are commonly made from sugar, cornstarch, gelatin, water, and added colorings. Jellifying agents, such as pectins, modified starches, gelatin, and sugars, form the foundation of gummy bears, allowing water-soluble elements to dissolve while insoluble ones are suspended in the viscous matrix. Main flavors of gummy vitamins include raspberry, lemon, orange, and cherry.
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
The following customization options are available for the report:
With the given market data, MarketsandMarkets offers customizations according to company-specific scientific needs.
Full forecast, segment splits, and company analysis for all Gummy Supplements Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report